Cardinal Health, Inc.
CAH Healthcare Medical Distribution
Cardinal Health, Inc.’s revenue for fiscal 2026 (year ended June 2026) was $254.2 billion, up 14.2% from fiscal 2025. In the quarter to June 2026, revenue grew 5.84%, EPS grew 68.3%, free cash flow grew 10.9% and total debt rose 4.21%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years.
Follow CAH
Cardinal Health, Inc. (CAH) Price to free cash flow
As of 16 October 2026, Cardinal Health, Inc. (CAH) trades at a price to free cash flow of 13.2×. Over the past ten years it has ranged from 0.0× (March 2025) to 41.7× (April 2017); the current reading is higher than 83% of that period. That is below the Healthcare sector median of 20.2×.
Price to free cash flow, daily
Embed this chart
Annual newest first
| Period | Price to free cash flow | Change |
|---|---|---|
| FY2026 | 12.3× | (43.68%) |
| FY2025 | 21.9× | 197.68% |
| FY2024 | 7.3× | (29.73%) |
| FY2023 | 10.4× | 101.92% |
| FY2022 | 5.2× | (37.04%) |
| FY2021 | 8.2× | (14.73%) |
| FY2020 | 9.6× | 61.67% |
| FY2019 | 6.0× | (7.64%) |
| FY2018 | 6.5× | (79.18%) |
| FY2017 | 31.0× | 204.46% |
Quarterly newest first
| Period | Price to free cash flow | Change |
|---|---|---|
| Jun 2026 | 12.3× | 9.43% |
| Mar 2026 | 11.2× | 28.36% |
| Dec 2025 | 8.8× | 4.47% |
| Sep 2025 | 8.4× | (61.62%) |
| 42 more quarters | Free account |
Against its own ten years
Price to free cash flow against peers
| Company | Price to free cash flow |
|---|---|
| HKPD Cellyan Biotechnology Co., Ltd compare | n/m |
| ACH Accendra Health, Inc. compare | n/m |
| FOCL FocalTherics compare | n/m |
| AHG Akso Health Group Sponsored ADR compare | n/m |
| COSM Cosmos Health Inc. compare | n/m |
| CAH Cardinal Health, Inc. | 13.2× |
| COR Cencora, Inc. compare | 16.0× |
| HSIC Henry Schein, Inc. compare | 17.2× |
| MCK McKesson Corporation compare | 19.5× |
| Healthcare sector median | 20.2× |
| Market median | 14.2× |
What Price to free cash flow is
Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.
Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))
More on CAH
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement